✦ LIBER ✦

387 The Focal Adhesion Kinase Inhibitor GSK2256098: a Potent and Selective Inhibitor for the Treatment of Cancer

✍ Scribed by Auger, K.R.; Smitheman, K.N.; Korenchuk, S.; McHugh, C.; Kruger, R.; Van Aller, G.S.; Smallwood, A.; Gontarek, R.R.; Faitg, T.; Johnson, N.

Book ID: 122943611
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 64 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(12)72185-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

564 Anti-tumour Activity of the Focal Ad

564 Anti-tumour Activity of the Focal Adhesion Kinase Inhibitor GSK2256098C in Ovarian Cancer

✍ Shenton, D. Doughty; McLeod, K.; Muir, M.; Kinnaird, A.; Gourley, C.; Carragher, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 63 KB

610 Loss of the Tumor Suppressor Merlin

610 Loss of the Tumor Suppressor Merlin as a Potential Predictive Biomarker of Clinical Activity for the Oral, Focal Adhesion Kinase (FAK) Inhibitor GSK2256098 in Pts with Recurrent Mesothelioma

✍ Soria, J.C.; Plummer, R.; Ranson, M.; Gan, H.; Arkenau, H.T.; Zalcman, G.; Blagd 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 58 KB

ARIMIDEX: a potent and selective aromata

ARIMIDEX: a potent and selective aromatase inhibitor for the treatment of advanced breast cancer

✍ Aman U. Buzdar; Walter Jonat; Anthony Howell; Paul V. Plourde 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 440 KB

Discovery of a Potent, Selective, and Or

Discovery of a Potent, Selective, and Orally Active Proteasome Inhibitor for the Treatment of Cancer

✍ Dorsey, Bruce D.; Iqbal, Mohamed; Chatterjee, Sankar; Menta, Ernesto; Bernardini 📂 Article 📅 2008 🏛 American Chemical Society 🌐 English ⚖ 161 KB

320 Identification of potent, selective,

320 Identification of potent, selective, soluble and permeable small molecule PI3 kinase inhibitors for the treatment of cancer

✍ K. Ahmadi; W. Alderton; I. Chuckowree; P. Depledge; A. Folkes; G. Pergl-Wilson; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 283 KB

A Scaleable Synthesis of BAY 43-9006: A

A Scaleable Synthesis of BAY 43-9006: A Potent Raf Kinase Inhibitor for the Treatment of Cancer

✍ Bankston, Donald; Dumas, Jacques; Natero, Reina; Riedl, Bernd; Monahan, Mary-Kat 📂 Article 📅 2002 🏛 American Chemical Society 🌐 English ⚖ 81 KB